Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

Cardiologists recommend complete revascularization, intravascular imaging in new ACS guidelines

The American College of Cardiology and American Heart Association published the new guidelines with assistance from other leading U.S. medical societies. 

Why cardiac CT adoption remains low among primary care providers

The rapid rise of CCTA represents one of cardiology’s biggest ongoing trends, but most primary care providers are still not embracing a CT-first strategy.

Charalambos Antoniades, MD, the British Heart Foundation Chair of Cardiovascular Medicine at the University of Oxford, is a co-founder of the company Caristo, which has developed technology to image coronary inflammation on coronary computed tomography angiography (CCTA) scans to visualize a key factor of residual cardiovascular risk.

Detecting coronary inflammation on CT imaging could reshape preventive cardiology

New technology now being considered by the FDA for approval can capture coronary inflammation on CCTA images and provide risk assessments. What could this mean for the future of cardiac care? We spoke to one researcher to learn more.

The new cardiac PET radiotracer flurpiridaz F-18 is posed to be a major game changer and will likely lead to increased adoption of cardiac PET.

‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

cardiac amyloidosis on bone scan

Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

Video of James Min, MD, explaining the future of cardiac care using CT and AI plaque analysis to create a personalized and more accurate cardiac risk assessment, similar to a mammogram for the heart.

Embracing the future: James Min left academia to push for a paradigm shift in preventive cardiology

James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology.

lung cancer pulmonary nodule

Opportunistic imaging detects signs of heart disease in lung cancer patients

These findings show that opportunistic imaging could go a long way toward making more patients aware of the cardiovascular risks they face—all without requiring additional scans to be performed. 

The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Displaying 17 - 24 of 1803

Around the web

Radiology Business
Tampa General radiology rides out 2 hurricanes with strategic disaster preparedness

Raj Kedar, MD, chief of imaging, discusses how the hospital planned to continue operations last fall when faced with hurricanes Helene and Milton.
 

Radiology Business
Enhancing STAT radiology exam order efficiency to reduce turnaround time

Raj Kedar, MD, chief of radiology at Tampa General Hospital, spoke on how to reduce the number of STAT imaging exams and inappropriate exams via staff education and additional questions of orders. 

 

Radiology Business
Tariffs threaten imaging access for patients, RBMA warns

Radiology practices are already operating on razor thin margins, with price increases prompting calls for congressional action to prevent further damage.